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Abstract
Background: Copy number variation (CNV) is a major component of genomic variation, yet methods to accurately type
genomic CNV lag behind methods that type single nucleotide variation. High-throughput sequencing can contribute to
these methods by using sequence read depth, which takes the number of reads that map to a given part of the reference
genome as a proxy for copy number of that region, and compares across samples. Furthermore, high-throughput
sequencing also provides information on the sequence differences between copies within and between individuals.
Methods: In this study we use high-coverage phase 3 exome sequences of the 1000 Genomes project to infer diploid
copy number of the beta-defensin genomic region, a well-studied CNV that carries several beta-defensin genes involved in
the antimicrobial response, signalling, and fertility. We also use these data to call sequence variants, a particular challenge
given the multicopy nature of the region.
Results: We confidently call copy number and sequence variation of the beta-defensin genes on 1285 samples from 26
global populations, validate copy number using Nanostring nCounter and triplex paralogue ratio test data. We use the
copy number calls to verify the genomic extent of the CNV and validate sequence calls using analysis of cloned PCR
products. We identify novel variation, mostly individually rare, predicted to alter amino-acid sequence in the beta-
defensin genes. Such novel variants may alter antimicrobial properties or have off-target receptor interactions, and may
contribute to individuality in immunological response and fertility.
Conclusions: Given that 81 % of identified sequence variants were not previously in dbSNP, we show that sequence
variation in multiallelic CNVs represent an unappreciated source of genomic diversity.
Keywords: Exome, High throughput sequencing, Copy number variation, Beta-defensin
Background
Copy number variation (CNV), where a section of DNA
differs from a diploid copy number of 2 between different
individuals, is a common form of variation that can affect a
substantial portion of the human genome and genomes
from other organisms [1–3]. Such variation can affect
phenotype through a variety of mechanisms, such as a gene
dosage effect [4], variation in the number of protein coding
domains [5] or alteration of position of enhancer elements
[6]. CNV can be divided into simple CNV, usually compris-
ing a deletion or duplication and generated by one muta-
tional event, and complex multiallelic CNV where different
dosage variants are generated by recurrent mutation. In
humans, complex CNV has been shown to affect disease
susceptibility. For example, CNV of the beta-defensin locus
has been shown to affect the risk of developing the inflam-
matory skin disease psoriasis [7, 8], and CNV of the neur-
onal glucose transporter SLC2A3 modifies the age of onset
of Huntington’s disease [9]. Furthermore, CNV of the amyl-
ase gene in dogs has been shown to be an adaptation to do-
mestication and in Drosophila CNV is important in
resistance to insecticides [10, 11].
Despite the importance of complex CNV, research pro-
gress has lagged behind studies into simpler deletions and
duplications, and has been dogged by false positive disease
associations. This is almost entirely due to the challenges
in accurately typing complex multiallelic CNV [12]. Most
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studies have used real-time quantitative PCR, which is prone
to bias [13, 14]. Although other more reliable methods exist,
such as the paralogue ratio test (PRT) and multiplex amplifi-
able probe hybridisation (MAPH), such assays require exten-
sive validation and are locus specific rather than genome-
wide, limiting the amount of data generated at one time.
Genome-wide approaches, such as analysis of hybridisation
signal intensities from SNP chips and array comparative gen-
omic hybridisation, generate a large amount of useful data
but are often weak in typing complex CNV – i.e. giving an
absolute copy number rather than just indicating a loss or
gain of signal. Furthermore, complex CNV detection and
typing appears to be DNA cohort dependent, which further
increases the risk of false negative genetic associations and
false positive associations due to batch effects.
Recent work has addressed analysis of CNVs using se-
quence read depth (SRD) generated by next-generation
sequencing platforms [4, 15]. The principle is simple:
when short read sequences are generated from an indi-
vidual with a high copy number for a particular region
and are subsequently aligned to a reference genome with
only one copy of that region, the number of reads map-
ping to that region will be higher than expected. Most
studies have focused on detecting CNV in whole gen-
ome sequences rather than typing absolute copy number
of particular complex CNV regions [16]. One exception
relies on singly-unique-nucleotides (SUNs) to provide an
internal calibration of copy number of that particular region
[15]. This has been successful for some CNVs, and using
this approach the role of a particular sequence variant of
the CNV carrying the SRGAP2 gene in human evolution
has been elucidated [17]. Nevertheless, the extent to which
other complex CNVs show that particular pattern of vari-
ation, where SUNs exist and are frequent, is not clear.
One distinct advantage of SRD approaches is that they
can yield information on the sequence differences between
different copies of the complex CNV. Other methods, such
as analysis of SNP array hybridisation intensity data, array
comparative genomic hybridisation (aCGH) data, MAPH
or PRT often assume sequence identity under the probe or
primer. The effect of this can be minimised either by mul-
tiple assays or careful design of probes/assays, but such
methods remain essentially blind to the sequence variation
between copies. This sequence variation can be important,
for example, in the SRGAP2 example mentioned above,
where only particular paralogues, defined by sequence vari-
ants, are functional [17].
An accurate assessment of sequence variation of a multi-
allelic CNV locus using SRD needs high coverage sequence
data to be confident that all copies have their sequence rep-
resented in the alignment. The number of publically-
available whole genomes sequenced at high coverage is
increasing but limited, but the 1000 Genome Project has
released sequence data of 2455 exomes sequenced at high
coverage using Illumina sequencing technology. Furthermore,
given the lower cost of exome sequencing per sample, exome
sequences are becoming increasingly common for large sam-
ple sets. Therefore we focused on complex CNV typing and
sequence analysis using high coverage exome sequence data.
There are several platforms that use exome SRD data
to detect and call CNV [16]. All use a similar approach
of using principal component analysis to extract compo-
nents describing different aspects of the variation, in-
cluding noise, and then using a hidden Markov model
approach to call boundaries between gain of copy number,
loss of copy number and diploid regions. In principle, the
variation in the principal component that most closely
corresponds to DNA dosage signal can be used to type
the absolute integer copy number of complex CNV. Only
one platform has been used to do this, CoNIFER, which
has been used on 907 exomes to show proof of principle
[18], and subsequently on 1644 exomes to investigate the
role of CNV in autism spectrum disorder [19].
To rigorously test the quality of copy number and se-
quence variation calls from exome data on a region of
complex CNV, we decided to focus on the well-studied
human beta-defensin locus. This is a 322 kb region of
DNA on chromosome 8p23.1, which is embedded within
a complex region rich in segmental duplications and
olfactory receptor genes [20, 21]. The 322 kb region is
copy number variable as a block, with the diploid copy
number commonly between 2 and 7 copies, but individ-
uals with as few as one copy and as many as 12 copies
have been observed [14, 22]. Chromosomes with high
copy number of the beta-defensin region can be distin-
guished by a visibly larger 8p23.1 region by G-band
staining [23]. Furthermore, the beta-defensin region is
polymorphic in physical location on the chromosome,
with some copies polymorphically at the proximal end
of 8p23.1 within the olfactory repeat region REPP in
addition to the distal end within the olfactory repeat re-
gion REPD [20].
Seventeen annotated genes are within the copy num-
ber variable region, including eight beta-defensin genes
(DEFB4, DEFB103, DEFB104, DEFB105, DEFB106,
DEFB107, DEFB108 and DEFB109) and nine other genes
mostly expressed in the testes [21]. The role of DEFB4
and DEFB103 appear to be immunomodulatory in
humans, in addition to direct antimicrobial activity. For
the other defensins, the role is less clear, although a
knockout mouse deleting the orthologous beta-defensin
cluster shows complete male infertility, strongly suggest-
ing an important role of these genes in reproduction [22].
The function of the other genes remains unknown. Se-
quence variation of the region remains understudied, pri-
marily due to the difficulty of reliably distinguishing
variant nucleotides in multicopy regions by the Sanger se-
quencing method. We therefore decided to test whether
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exome SRD could accurately call copy number and se-
quence variation of this complex CNV, both to identify
beta-defensin variants which may have novel functions
but also to robustly establish a recommended approach




Filtered phase 3 exome data generated by the 1000 Gen-
ome project was downloaded from the European Bio-
informatics Institute (http://ftp.1000genomes.ebi.ac.uk/
vol1/) as fastq files. We retrieved only Illumina tech-
nology filtered paired end data generated by four dif-
ferent sequencing centres: Baylor College of Medicine
(BCM), Beijing Genomic Institute (BGI), Broad Institute
(BI), and Washington University Genome Sequencing
Center (WUGSC). The initial dataset consisted of 2455
samples divided in 5 major continental groups (referred to
as “super populations” by the 1000 Genomes Project):
African, East Asian, South Asian, European, and Admixed
American. Throughout this paper, the standard abbrevia-
tions for 1000 Genomes populations are used – see http://
www.1000genomes.org/category/frequently-asked-questions/
population for details of population codes and sample
names.
Mapping
The reference sequence was generated using all chromo-
some 8 exons plus 300 bp flanking sequence from the
GRCh37-hg19 human reference genome; when two exons
were closer than 600 bp, all the genomic distance was
considered. We used mrsFAST ultra v3.2.0 for sequence
alignment, using a paired end approach [24]. Importantly,
ConIFER was designed to be used on alignments gener-
ated using mrsFAST [25], a one-to many sequence read
aligner, rather than other more common aligners based on
the Burrows-Wheeler algorithm that generally operate as
a one-to-one sequence aligner. mrsFAST therefore cap-
tures all possible mapping locations up to a user-defined
number of mismatches, which leads to more accurate esti-
mates of copy number from SRD approaches, because all
copies above a given percentage identity will be aligned
efficiently to the reference locus. A reference indexing
window size of 12 was created and the pair end reads
mapping was performed using the all-mapper tool with a
maximum error threshold of 6.
CNV calling
CNV calling used CoNIFER, a suite of Python scripts that
calculate RPKM (reads per thousand bases per million
reads sequenced) values starting from aligned sequences
and a set of probes [18]; for our analyses we defined the
probe set as all the chr8 exon boundaries. Samples with a
RPKM mean <50 were discarded from the analysis to re-
duce background signal. Singular value decomposition
standardized z-scores RPKM (SVD-ZRPKM) values were
calculated for samples belonging to one or more popula-
tion generated by the same sequencing centre (e.g. all
African samples from BGI), removing the first compo-
nents that are disproportionally responsible for the vari-
ance of the data. For each dataset under analysis, we
evaluated the best number of components to be removed
using scree plots generated by CoNIFER; the components
to be removed were chosen based on the shoulder of the
scree plot. Raw SVD-ZRPKM mean of the beta-defensins























Fig. 1 Distribution of reads-per-kilobase-per-million-reads (RPKM) values of different samples stratified by sequencing centre. The kernel density plot
shows density of RPKM values from mrsFAST alignments for four different sequencing centres, distinguished by the different colours. The vertical dotted
line indicates the cutoff value at RPKM= 50, with samples above that threshold taken on for copy number calling
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that unambiguously map just to chromosome 8p23.1
DEFB4, DEFB103, DEFB104, DEFB105, DEFB106 and
DEFB107) were retrieved and used for CNV calling. To
determine the integer copy number call for each sample
we used CNVtools, grouping samples from the same con-
tinental group and sequencing centre together. The
Gaussian mixture models were evaluated by eye, plotting
the mixture model together with a histogram of raw copy
number to check for clear clustering about integer copy
numbers, and also by comparing calls with previous copy
number estimates of samples from the HapMap collection
that overlapped the 1000 Genomes dataset, using triplex
paralogue ratio tests [26]. These positive controls also
allowed us to confirm that the correct SVD-ZRPKM com-
ponent was used for copy number calling.
Variant calling
Single nucleotide variants in one assembled beta-defensin
region were called using FreeBayes v9.9.2 [27]. Freebayes
is a haplotype-based Bayesian genetic variant detector,
which can call sequence variants from samples of different
ploidy, with ploidy (equivalent to, in our case, copy
number) as an extra parameter for each sample. We
ran FreeBayes setting 30 and 50 as minimum base
and mapping quality, respectively; 0.10 as the mini-
mum fraction of alternate variant observations and 10
for the minimum count of alternate variant reads; finally
we specified for each sample the number of copies of the
beta-defensin region estimated by the CoNIFER exome
SRD analysis.
Validation of copy number
Copy number estimates of 164 samples from the HapMap
collection that overlapped the 1000 Genomes dataset,
using triplex paralogue ratio tests, have been published
previously. Copy number estimates of the same samples
were also obtained using the Nanostring nCounter system
[28], by designing 6 probes mapping to the beta-defensin
repeat and calculating the first principal component,
sample-wise, of the 6 probe values using the R package
CNVtools [29].
Validation of sequence variants
PCR primers were designed flanking variable sites, and gen-
omic DNA from a selection of 8 HapMap samples ampli-
fied using standard PCR. PCR products were then cloned
into pJET 1.2 vector using the CloneJet PCR cloning kit
(Thermo Scientific), where the insert disrupts a lethal gene
allowing only plasmids with an insert to confer viability to
the bacterial host. Following plating, colonies were selected
for colony PCR using the vector primers 5’CGA
CTCACTATAGGGAGAGCGGC-3’ and 5’AAGAACATC-
GATTTTCCATGGCAG-3’ flanking the insert, according
to the manufacturer’s instructions. PCR products were then
digested using the appropriate restriction enzyme to distin-
guish the alleles at the variant site (MspI for
rs140952426, ApeKI for rs200757797) and scored for
allelic state following agarose gel electrophoresis.
Population genetics
Variant frequency distributions for non-synonymous and
synonymous variants were compared across the beta-
defensin genes analysed, for each population, using the
k-sample Anderson-Darling test [30] implemented by
the R package kSamples.
Availability of data
One thousand Genomes phase 3 exome read data are
publically available from the European Bioinformatics
Institute European Bioinformatics Institute (http://
ftp.1000genomes.ebi.ac.uk/vol1/) as fastq files. All 1285
confident copy number calls have been submitted to
dbVar (http://www.ncbi.nlm.nih.gov/dbvar) with acces-
sion number nstd116. All novel variants identified in this
paper have been deposited in dbSNP (http://
www.ncbi.nlm.nih.gov/SNP/).
Ethics statement
For a description of the ethics and consent agree-
ments used for the 1000 Genomes Project see http://
www.1000genomes.org/about.
Table 1 Characteristics of exome sequences analysed
Centre name Samples Samples with > 50 reads
per exon
Sample with a copy
number call
Samples with a copy number
call P > 0.95*
Sequence enrichment
method
BCM 228 228 147 129 (88 %) HSGC VCRome custom array
BGI 894 866 866 795 (91 %) NimbleGen
SeqCap_EZ_Exome v2
BI 830 161 161 140 (87 %) Agilent
SureSelect_All_Exon_V2
WUGSC 503 397 288 221 (76 %) NimbleGen
SeqCap_EZ_Exome v3
*posterior probability of the copy number call is >0.95
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Results
We aligned fastq raw sequence read files for 2455 samples
from 26 populations to a concatenated reference sequence
made of all chromosome 8 exons plus 300 bp flanking se-
quence. We grouped the samples from the 26 populations
into four continental groups. After removing samples where
the reads per kilobase per million mapped reads (RPKM)
mean value was less than 50, (Fig. 1, Table 1) we calculated
single variant decomposition scores batch wise, with each
batch representing a distinct continental group/sequencing
centre combination. Raw SVD-ZRPKM mean of all exons
of the beta-defensin genes were retrieved and a Gaussian
mixture model fitted for each set of data using CNVtools.
Observing clear clustering of SVD-ZRPKM mean values
about integer copy number values leads us to have high
confidence in the Gaussian mixture model fit and therefore
in the final copy number calls. Importantly, batches needed
to be defined by both sequencing centre and continental
group, otherwise poor clustering was observed. For ex-
ample, Fig. 2 shows histograms of raw SVD-ZRPKM mean
values from the BGI sequencing centre, for East Asians
(Fig. 2a), South Asians (Fig. 2b) and East and South Asians
together (Fig. 2c). Although a Gaussian mixture model can
be fitted for all three histograms, the clustering of the SVD-
ZRPKM values of the combined batches (Fig. 2c) is visibly
less distinct than when each batch is analysed separately.
For most batches, clear clustering of raw SVD-ZRPKM
values was observed, increasing confidence that the correct
copy number was being called (Fig. 3a). However some
showed SVD-ZRPKM values that did not cluster well (e.g.
African samples from BCM sequencing centre, Fig. 3b),
and these were removed from subsequent analyses.
Gaussian mixture modelling generated a copy number
call for each sample with an associated posterior probabil-
ity of that call. The proportion of calls with a posterior
probability greater than 0.95 varied between sequencing
centres (Table 1), but overall was 87 %. The distribution of
copy number reflected previous results, with 4 being the
modal copy number in all continental groups apart from
sub-Saharan Africans, and the range of common variation
extending from 2 copies to 8 copies per diploid genome
(Table 2).
We validated our copy number calls by comparing
calls on a subset of samples with copy number estimates
made previously by Triplex PRT [13, 26], by Nanostring
[28] (Fig. 4a), and also with copy number calls of the re-
gion made by whole genome sequencing [4] (Fig. 4b). It
is clear that copy number calls made using exome SRD
agree well with both PRT and Nanostring consensus
copy number. Exome SRD calls also agree well with
whole genome SRD data, although there is a significant
discrepancy rate of 11.8 %. Most discrepancies are at the
higher copy numbers, and seem to be due to exome
SRD underestimating copy number. Of the 7 samples
that are discrepant between exome SRD and both PRT
and Nanostring, three are also discrepant with whole
genome SRD copy number calls, all are spread across
the different sequencing centres (Table 3), suggesting
the discrepancies are due to random assay noise rather
than a systematic bias.
We used our exome SRD data to investigate the extent
of contiguous copy number variation at this locus, gene
East Asian populations
South Asian populations









































Fig. 2 Effects of continental group batch of origin on copy number
clustering. The histograms show normalised sequence depth coverage
data for the beta-defensin region generated by the BGI sequencing
centre. X-axis values represent raw mean SVD-ZRPKM values, and the
y-axis represents number of samples. Curved lines indicating the
Gaussian curves used to call integer copy number. a) samples from East
Asian populations (n= 269), b) samples from South Asian populations
(n= 165), c) samples from South Asian and East Asian populations
analysed as one batch (n= 434)
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by gene. Individual SVD-ZRPKM mean values of each
gene were correlated with the individual SVD-ZRPKM
mean values of genes within and surrounding the beta-
defensin CNV region, both at distal 8p23.1 (a region
called REPD [31]), and proximal 8p23.1 (REPP), across
the 171 European samples sequenced at the BGI. We
would expect genes on the CNV block to show highly
correlated SVD-ZRPKM scores across these individuals,
reflecting the CNV. Indeed, the core defensin genes
(DEFB4 to DEFB107) showed a very high correlation
(Fig. 5) indicating that these are on a contiguous block
that shows CNV. This block of highly correlated genes ex-
tends distally as far as FAM90A13 and includes DEFB109,
albeit with lower correlation coefficients, which is likely to
be due to mapping of sequence reads derived from known
segmental duplications involving these genes on chromo-
some 4 and chromosome 12. This confirms the observa-
tion made previously using arrayCGH that these genes are
involved in the beta-defensin CNV [21], and shows that
analysis of exome SRD can be a powerful approach to
identify CNV boundaries. Interestingly, a moderate
correlation coefficient is observed for some genes at
REPP, including DEFB130 but not DEFB134, DEFB135
nor DEFB136. The beta-defensin repeat region (in-
volving DEFB4 to FAM90A13) is not assembled here,
but it is known from genetic data that the repeat region
can be polymorphically present here at this location [20],
and this signal we observe is likely to be due to CNV of
the beta-defensin repeat region at REPP.
We used our exome alignment files to call sequence
variation across the beta-defensin genes within the CNV.
Using FreeBayes, a sequence caller that uses diploid
copy number as an extra parameter and therefore can
make sequence variant calls from non-diploid regions,
we called 436 single nucleotide variants spanning
8811 bp of sequence representing the combined length
of the beta-defensin genes. 299 are intronic or inter-
genic, with 137 within the untranslated regions or cod-
ing regions. The majority of variants called are rare or
very rare, and are specific to particular continental
groups, suggesting that they have arisen very recently in
human evolutionary history. 355 variants (81 % of total)
are novel and have been submitted to dbSNP.
Sixty-seven variants (64 non-synonymous substitutions
and 3 stop codon gains) were called that were predicted
to affect amino acids within the beta-defensin genes
Fig. 3 Effects of sequencing centre and batch size on copy number clustering. The histograms show normalised sequence depth coverage data
for the beta-defensin region for sub-Saharan African samples. X-axis values represent raw mean SVD-ZRPKM values a) BCM sequencing
centre, n = 81 (15 YRI, 57 LWK, 9 ASW). b) BGI sequencing centre, n = 172 (26 YRI, 3 LWK, 25 GWD, 43 MSL, 47 ESN, 5 ASW, 23 ACB), with
curved lines indicating the Gaussian mixture model used to call integer copy number
Table 2 Beta-defensin copy number frequency in human continental groups
Continental group Total Samples 2 copy 3 copy 4 copy 5 copy 6 copy 7 copy 8 copy
Sub-Saharan African 214 1 (0.005) 26 (0.12) 60 (0.28) 68 (0.32) 38 (0.18) 16 (0.07) 5 (0.02)
East Asian 405 13 (0.03) 81 (0.200) 153 (0.38) 112 (0.28) 34 (0.08) 10 (0.02) 2 (0.005)
South Asian 248 9 (0.04) 41 (0.17) 97 (0.39) 66 (0.27) 32 (0.13) 3 (0.01) 0
European 349 7 (0.02) 50 (0.14) 142 (0.41) 109 (0.31) 35 (0.10) 6 (0.02) 0
Admixed American 246 6 (0.02) 49 (0.20) 113 (0.46) 64 (0.26) 12 (0.05) 2 (0.008) 0
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(Fig. 6). We validated two frequent non-synonymous
variants, rs140952426 in DEFB104 that changes arginine
to a glutamine at position 38, and rs200757797 in
DEFB105 that changes a cysteine to a tyrosine at pos-
ition 73. It was important not only to validate the pres-
ence of the variant but also the correct number of
copies of that variant. We did this by amplifying across
the variant using genomic DNA, cloning the resulting
PCR product, and then counting the number of clones
(each derived from a single amplified DNA molecule
from the PCR) that had each allele of the variant using
colony PCR followed by restriction enzyme digestion
(Table 4). This gave an estimate of the proportion of
each allele at each variant for each sample, which could
be then compared with that predicted by exome sequen-
cing – for example a GGGA genotype (where three copies
have a G and one copy has an A at the same paralogous
nucleotide site) would be regarded as 0.25 A allele. For
both variants, samples homozygous for the variant that is
cut by the restriction enzyme was included to provide a
background rate of cut failure either due to experimental
error or mutation of restriction site during amplification
and cloning. The proportion of each allele measured using
this approach is consistent with the genotype called from
exome SRD data for all samples, except one. The excep-
tion is NA12763, where the molecular cloning method
generates an estimate which agrees with a copy number of
6 called by PRT rather than a copy number of 4 called by
exome SRD, and therefore reflects an error in copy num-
ber calling by exome SRD.
We considered whether a signature of selection at
these beta-defensin genes could be inferred from the
frequency of sequence variants. By comparing the se-
quence variant frequency distribution of non-synonymous
and synonymous SNPs within coding regions, it is possible
to detect the effect of negative selection or balancing se-
lection across the region. Assuming that selection does
not act on synonymous variants and therefore their vari-
ant frequency distribution represents the neutral null
model, we would expect to see an enrichment of non-
synonymous variants at low frequency under negative
selection, and an enrichment of non-synonymous variants
at high frequency (0.4-0.5) under balancing selection.
Given the small exon size and therefore small number
of polymorphisms in the coding region of each gene, we
compared the sequence variant frequency distribution
for each continental group separately, combining data
across all beta-defensin genes measured in the CNV. We
did not find a statistically significant difference between
any non-synonymous and synonymous sequence variant
frequency distributions, for any of the continental
groups. This suggests that selection is not acting on
these genes, and that the sequence variants observed
are essentially neutral.
Discussion
In this study we show that high coverage exome sequen-
cing can effectively report integer copy number and se-
quence variation between copies. Focusing on exome
sequencing data has two disadvantages compared to
whole genome sequencing data. Firstly, typing depends
on the presence of exons (or, more correctly, baits in the
exome enrichment mix) that map within the complex
CNV region. It is obvious that if there are no exons
(See figure on previous page.)
Fig. 4 Validated of beta-defensin copy number calling. The plots show comparisons between two methods of calling integer beta-defensin copy
number. a) comparison with triplex paralogue ratio test and Nanostring nCounter. b) comparison with integer calls from phase 1 low coverage
whole genome data [4]. The figures in red indicate the numbers of samples concordant for that particular copy number. The numbers in blue
indicate the numbers of discordant samples
Table 3 Discrepant copy number calls between exome sequence read depth (SRD) analysis and previous analyses






Copy number from whole
genome SRD
NA18858 YRI BGI 0.589 6 8 8
NA18861 YRI BGI 0.996 5 6 6
NA11892 CEU BGI 0.968 3 5 3
NA11893 CEU BGI 0.977 4 5 5
NA12156 CEU BCM 0.610 5 6 na
NA18912 YRI BI 0.982 6 5 6
NA12761 CEU WUGSC 0.995 4 3 na
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Fig. 5 Correlation of SVD-ZRPKM values between genes at 8p23.1. Plot of pairwise correlation between SVD-ZRPKM values among genes at
chromosome region 8p23.1. The SVD-ZRPKM mean for all exons belonging to each gene was calculated and the pairwise correlation for each pair
of genes was evaluated by the r2 metric (the correlation is increasing with gray shading). Gene presence and location is based on the annotation
of the hg19 human genome assembly. Complex repeat-rich regions REPP and REPD are indicated, and several genes between REPP and REPD
are omitted to save space, as indicated by the red dashed line
Fig. 6 Summary of predicted amino acid changes inferred from sequence variation. The six beta-defensin proteins encoded by the genes analysed in
this study are shown. The prepro region, which is cleaved during processing, is shown under the blue bar; with the mature peptide sequence is shown
under the red bar. The canonical six cysteines are highlighted in red, with sequence variants identified in this study shown in green. X represents a stop
codon, and hbd2, hbd3, hbd4, hbd5, hbd6, and hbd7 are the proteins encoded by DEFB4, DEFB103, DEFB104, DEFB105, DEFB106 and DEFB107 respectively
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within the CNV, the sequence will not be enriched and
no (or very little) sequence will be generated from that
CNV. The problem is scalar, in that it is likely that CNVs
with more exonic sequence will have more sequence
reads and therefore be more effectively called using SRD
approaches compared to CNVs with a small amount of
exonic sequence. Secondly, exome sequencing relies on
solution-phase enrichment of fragmented DNA using
sequence-specific baits. Such an enrichment process
might introduce bias into copy number calling, dependent
on GC-content of the region or experimental batch, for
example.
Future studies need to be aware of several issues that
are important to consider when inferring integer copy
number from exome SRD. Firstly, in this study we knew
a priori the extent of CNV, which had been elucidated
previously, so allowing us to choose several genes which
we know were contained in a contiguous CNV block. In-
ferring CNV boundaries from exome data, particularly
when those boundaries are within gene sparse areas or
segmental duplications, may result in noisier SRD data,
although we show that once a CNV can be robustly
typed, the boundary of the CNV can be refined on a
gene-by-gene basis. Secondly, we had a number of posi-
tive controls where copy number was well established
using other methods. This allowed us to validate our sin-
gular value decomposition components and our Gaussian
mixture models, giving us confidence in our final copy
number calls. Thirdly, particular population-sequencing
centre batches of samples gave distinct raw copy number
results, suggesting that fitting individual Gaussian mixture
models to individual batches is important. We do not
know what causes this variation, and why sometimes it
prevents clustering of raw copy number results, but we
suspect it might be due to subtly different signal-noise
structures in the data because of different exome enrich-
ment processes used by different centres, which SVD
cannot completely resolve. If correct, then we predict
that high-coverage whole genome sequences will not
show this problem.
One previous study used target enrichment and 454
sequencing of over 87 kb of the beta-defensin CNV in
two samples to study sequence variation [32]. This study
had the advantage of revealing variation in non-coding
regions, and, together with the longer reads generated
by 454 technology, sequence haplotypes could be in-
ferred. However, CNV calling by read depth was not
attempted and some sequence variants, particularly rare
variants, were called with a small number of supporting
reads, suggesting limited sensitivity of the approach. Fur-
thermore, only two European samples were sequenced,
revealing a limited part of the total potential sequence
variation of the region.
By comparing sequenced BACs, we have previously
shown that sequence differences between different cop-
ies is localised particularly immediately upstream and
downstream of genes, and this may result in expression
differences between different copies of the same gene.
Indeed, both luciferase reporter studies in keratinocytes
and expression in lymphoblastoid cell lines have shown
that variation between different defensin copies affects
expression of DEFB103 and of DEFB4 [26, 33]. The sin-
gle nucleotide variation affecting DEFB103 expression is
within 1 kb immediately 5’ of the transcription start site,
but the single nucleotide variation affecting DEFB4 ex-
pression is not known, except that it is tagged by a
synonymous polymorphism rs2740090, which is re-
ported as common across all the continental groups
studied here (Additional file 1: Table S1). Our previ-
ous observations of increased sequence differentiation
upstream of DEFB103, together with its functional ef-
fect and the population distribution differences, have
led us to suggest that natural selection has influenced
expression levels of at least DEFB103 [26]. Further-
more, given the gene dosage effect of copy number
variation observed at this locus [34, 35], gene copy
Table 4 Validation of single nucleotide variants
Sample rs140952426 rs200757797
Uncut (A) Cut (G) Proportion A (95 % CI) From exome Uncut (T) Cut (C) Proportion T (95 % CI) From exome
NA07056 60 41 0.59 (0.49-0.69) AAGG 3 84 0.03 (0.01-0.10) CCCC
NA12044 4 74 0.05 (0.01-0.13) GGGG 18 53 0.25 (0.16-0.37) CCCT
NA18956 44 123 0.26 (0.20-0.34) AGGG - - - CCCC
NA12004 37 139 0.21 (0.15-0.28) AGGG - - - CCCC
NA12156 13 146 0.08 (0.04-0.14) AGGGG - - - CCCCC
NA07357 - - - GGGGGG 5 79 0.06 (0.02-0.13) CCCCCT
NA12763 - - - GGGG 22 178 0.11 (0.07-0.16) CCCTa
NA12874 - - - GGGG 16 52 0.23 (0.14-0.35) CCCT
95 % confidence intervals of the binomial distribution calculated using the Pearson-Klopper method
aCalled as 6 copies by previous PRT
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number results in variation in levels of protein which in
turn provides a phenotype upon which selection can act.
In contrast, in rhesus macaques [21] and dogs [36] it
seems likely that amino acid sequence variation between
copies has been subject to natural selection.
In Africa, all variants that alter amino acids in the
defensin genes are rare, but outside some of these vari-
ants have risen to increased frequency. In particular, a
variant at DEFB105 (rs700757797), which disrupts the
fifth canonical cysteine essential for disulphide bridge
formation in the mature protein (Fig. 6), is common in
non-African populations (Additional file 1: Table S1).
The functional consequences of this and other variants
are not known, and await further study. It is likely that
they are variants with little effect or null variants, result-
ing in proteins with reduced function. In the context of
a multicopy gene, one or two copies with little or no
function will have little consequence, particularly at
higher copy numbers, therefore negative selection
against such variants is likely to be weak, and indeed we
could not detect any signature of selection using variant
frequency distributions. An alternative view is that some
variants may have alternative off-target effects, and that
we have little power to detect selection at a small num-
ber of such variants. Indeed given the known receptor
promiscuity of defensins [37] and the influence of
structural changes on antimicrobial activity [38, 39]
this is a possibility worth exploring in the context of
novel therapeutic agents.
Conclusions
We have used exome sequence data from the 1000
Genomes Project to call copy number for the human
beta-defensin region on 1285 individuals. We have also
identified 436 sequence variants that differ between cop-
ies and between individuals, mostly rare, of which 67 are
predicted to affect amino-acid sequence of one of the
beta-defensin genes.
Additional file
Additional file 1: Table S1. Frequency of rs200757797 and rs2740090
in the 1000 Genomes continental groups. (DOCX 13.4 kb)
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